Top Story

Low-dose rivaroxaban reduces risk in PAD post-revascularization

Low-dose rivaroxaban reduces risk in PAD post-revascularization
March 28, 2020

Read the Perspective from Carl J. Pepine, MD


Cath lab concerns prompted by COVID-19

March 25, 2020
As more is learned about the COVID-19 pandemic, cardiology societies have issued advisories with steps to take in the cardiac catheterization laboratory to ensure…
The Take Home

The Take Home: ISET

February 18, 2020
The International Symposium on Endovascular Therapy, held Jan. 22 to 25 in Hollywood, Florida, tackled many of the hottest topics in endovascular intervention. To obtain…
In the Journals

No 5-year mortality signal in trial of PCB for below-the-knee lesions

February 17, 2020
A paclitaxel-coated balloon was not associated with elevated mortality risk in patients who underwent revascularization for critical limb ischemia, according to 5-year…
More Headlines »

Medical Therapies Provide Options for PAD Treatment

Cardiology Today's Intervention, January/February 2019
In recent years, data have emerged showing a variety of medical therapies can improve outcomes of patients with…
More »
Meeting News

VIDEO: A fellow's reaction to hands-on learning at TCT 2018

October 14, 2018
More »
In the Journals

Subsequent risk elevated after hospitalization for major adverse limb events

February 12, 2020
Among patients who underwent peripheral artery revascularization, those who were subsequently hospitalized at least…
More »